Expression of Concern: WR279,396, a third generation aminoglycoside ointment for the treatment of Leishmania major cutaneous leishmaniasis: A phase 2, randomized, double blind, placebo controlled study

PLoS neglected tropical diseases 2026 Open access

Read full text
Authors: The PLOS Neglected Tropical Diseases Editors
DOI: 10.1371/journal.pntd.0014047
Cited by: 0
References: 1

Abstract

Expression of Concern: WR279,396, a third generation aminoglycoside ointment for the treatment of Leishmania major cutaneous leishmaniasis: A phase 2, randomized, double blind, placebo controlled study

Fields of Study & Subjects

Research on Leishmaniasis Studies Leprosy Research and Treatment Leech Biology and Applications

Publication details

Journal / source
PLoS neglected tropical diseases
Volume
20
Issue
3
Pages
e0014047–e0014047
Publication date
5 March 2026
Language
EN